Both in Biotechnology
Aura Biosciences vs Prime Medicine
Over the past year AURA returned −0.3% and PRME returned −41.9%; their daily moves had a correlation of 0.31.
AURA −0.3% PRME −41.9%Growth of $1, one year, split-adjusted
| Metric | AURA | PRME |
|---|---|---|
| Price | $6.15 | $3.09 |
| Market cap | $637.8M | $560.5M |
| Today | 0.00% | +7.48% |
| 1 month | −16.9% | −14.4% |
| 6 months | −0.8% | −1.9% |
| Year to date | +12.8% | −11.0% |
| 1 year | −0.2% | −39.6% |
| Revenue growth (YoY) | — | +3.5% |
| Gross margin | — | 100.0% |
| Net margin | — | −3649.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 137.6× |
| Net cash | $323.8M | $95.1M |
| Dividend yield | — | — |
| Volatility (60d) | 41.2% | 85.9% |
| Short % of float | 7.8% | 33.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).